K7M2 wt Cells
| Unit |
3 x 10^6 cells/ml |
|---|---|
| Cell Type |
Tumor Cells |
| Tissue Type |
Mouse cell lines |
| Organism |
Mouse |
| Donor History |
Mouse osteosarcoma |
| Growth Properties |
Adherent |
| Growth Conditions |
Culture medium: DMEM ,w: 4.5 g/L Glucose ,w: 4 mM L-Glutamine ,w: 3.7 g/L NaHCO3 ,w: 1.0 mM Sodium pyruvate (Cytion article number 820300a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium ,we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability ,or CM-1 (Cytion catalog number 800100) ,which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C ,5% CO2 ,humidified atmosphere. |
| Immortalization Method | |
| Full Information |
The K7M2 wt cell line is derived from a murine osteosarcoma and is frequently utilized in cancer research, particularly for studies investigating the pathogenesis and therapeutic response of osteosarcoma. This cell line is characterized by its high metastatic potential, making it an invaluable model for studying the mechanisms underlying cancer metastasis and for testing anti-metastatic agents. K7M2 wt cells display a typical epithelial morphology and exhibit robust growth in vitro, which facilitates various experimental applications including gene expression studies, drug screening, and genetic manipulation.
Researchers leverage the K7M2 wt cell line to explore the molecular and cellular processes involved in osteosarcoma progression. Studies often focus on signaling pathways, such as the Wnt/β-catenin and PI3K/AKT pathways, which are crucial in tumor growth and metastasis. The genetic profile of K7M2 wt cells includes alterations common in osteosarcoma, providing insights into the genetic drivers of this malignancy. Furthermore, this cell line is instrumental in preclinical testing of new therapeutic approaches, including targeted therapies and immunotherapies, offering a platform for translating research findings into potential clinical applications.
Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.
Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Čtečky identifikačních čipů
Termočipy
Biochemie
Imunoanalýza

